We tested SNPs in two genes (HMGCR and NPC1L1) related to dyslipidemia in PTVD patients treated with moderate-intensity statins, and investigated the association between their SNPs and RCR (LDL-C > 1.8 mmol/L). This evidence concerns the gene NPC1L1 and metabolic syndrome.